Transformation of HF Care: SGLT2is as the New Pillar in HF

The American College of Cardiology (ACC) has created practical point-of-care guidance, in the form of an Infographic and a Pocket Guide, to address common clinical questions and challenges regarding the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in the management of patients with heart failure. These tools were designed to better prepare clinicians to confidently implement SGLT2is through optimal patient selection, initiation, and sequencing.

These clinician-facing tools include key information from the following clinical policies:

SGLT2i POCKET GUIDE Thumbnail

SGLT2i POCKET GUIDE

This pocket guide is a practical, streamlined resource for clinicians regarding the use of SGLT2is when managing patients with heart failure.

DOWNLOAD POCKET GUIDE
SGLT2i INFOGRAPHIC Thumbnail

SGLT2i INFOGRAPHIC

This infographic offers information about safe prescribing and use of SGLT2is in patients with stage C & D heart failure.

DOWNLOAD INFOGRAPHIC


The pocket guide and infographic were created with support from by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company, LLC.